메뉴 건너뛰기




Volumn 22, Issue 5, 2014, Pages 1217-1222

Romiplostim for management of chemotherapy-induced thrombocytopenia

Author keywords

Chemotherapy; Romiplostim; Thrombocytopenia

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; ENOXAPARIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN; ROMIPLOSTIM;

EID: 84897518417     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-2074-2     Document Type: Article
Times cited : (68)

References (21)
  • 2
    • 77953896640 scopus 로고    scopus 로고
    • Biology and chemistry of thrombopoietic agents
    • Kuter DJ (2010) Biology and chemistry of thrombopoietic agents. Semin Hematol 47:243-248
    • (2010) Semin Hematol , vol.47 , pp. 243-248
    • Kuter, D.J.1
  • 3
    • 0037111558 scopus 로고    scopus 로고
    • Recombinant human thrombopoietin: Basic biology and evaluation of clinical studies
    • DOI 10.1182/blood.V100.10.3457
    • Kuter DJ, Begley CG (2002) Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 100:3457-3469 (Pubitemid 35303910)
    • (2002) Blood , vol.100 , Issue.10 , pp. 3457-3469
    • Kuter, D.J.1    Glenn, B.C.2
  • 4
    • 0035760892 scopus 로고    scopus 로고
    • Thrombocytopenia caused by the development of antibodies to thrombopoietin
    • Li J, Yang C, Xia Yet al (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98:3241- 3248
    • (2001) Blood , vol.98 , pp. 3241-3248
    • Li, J.1    Yang, C.2    Xia, Y.3
  • 5
    • 0034074551 scopus 로고    scopus 로고
    • Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia
    • Vadhan-Raj S (2000) Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia. Semin Hematol 37:28-34
    • (2000) Semin Hematol , vol.37 , pp. 28-34
    • Vadhan-Raj, S.1
  • 6
    • 0346881171 scopus 로고    scopus 로고
    • AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl
    • DOI 10.1016/j.cyto.2003.05.001
    • Broudy VC, Lin NL (2004) AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 25:52-60 (Pubitemid 38018897)
    • (2004) Cytokine , vol.25 , Issue.2 , pp. 52-60
    • Broudy, V.C.1    Lin, N.L.2
  • 7
    • 77953896640 scopus 로고    scopus 로고
    • Biology and chemistry of thrombopoietic agents
    • Kuter DJ (2010) Biology and chemistry of thrombopoietic agents. Semin Hematol 47:243-248
    • (2010) Semin Hematol , vol.47 , pp. 243-248
    • Kuter, D.J.1
  • 8
    • 84859389743 scopus 로고    scopus 로고
    • Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics
    • Liebman HA, Pullarkat V (2011) Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics. Hematol Am Soc Hematol Educ Program 2011:384-390
    • (2011) Hematol Am Soc Hematol Educ Program , vol.2011 , pp. 384-390
    • Liebman, H.A.1    Pullarkat, V.2
  • 9
    • 79952708977 scopus 로고    scopus 로고
    • Safety of romiplostim for treatment of severe chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma receiving multi-cycle chemotherapy: Results from an open-label dose- and schedule-finding study
    • abstract
    • Fanale M, Stiff P, Noonan K et al (2009) Safety of romiplostim for treatment of severe chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma receiving multi-cycle chemotherapy: results from an open-label dose- and schedule-finding study (abstract). EJC Suppl 7:563-563
    • (2009) EJC Suppl , vol.7 , pp. 563-563
    • Fanale, M.1    Stiff, P.2    Noonan, K.3
  • 10
    • 79952703515 scopus 로고    scopus 로고
    • Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC)
    • abstract
    • Natale R, Charu V, Schutte Wet al (2009) Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC) (abstract). EJC Suppl 7:574-574
    • (2009) EJC Suppl , vol.7 , pp. 574-574
    • Natale, R.1    Charu, V.2    Schutte, W.3
  • 11
    • 84897485589 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, dose and schedule-finding study of AMG531 In chemotherapy-induced thrombocytopenia (CIT): Results of a phase I/II study
    • abstract
    • Vadhan-Raj S, Hagemeister F, Fayad LE et al (2010) Randomized, double-blind, placebo-controlled, dose and schedule-finding study of AMG531 In chemotherapy-induced thrombocytopenia (CIT): results of a phase I/II study (abstract). Blood 116:656-657
    • (2010) Blood , vol.116 , pp. 656-657
    • Vadhan-Raj, S.1    Hagemeister, F.2    Fayad, L.E.3
  • 12
    • 84897533313 scopus 로고    scopus 로고
    • Safety and efficacy of eltrombopag (epag) versus placebo (pbo) for the treatment (tx) of chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors receiving gemcitabine (gem)-based chemotherapy (ctx): A phase I study
    • Winer ES, Safran H, Karaszewska B, et al.: Safety and efficacy of eltrombopag (epag) versus placebo (pbo) for the treatment (tx) of chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors receiving gemcitabine (gem)-based chemotherapy (ctx): A phase I study. J Clin Oncol (suppl) 30, 2012
    • (2012) J Clin Oncol , Issue.SUPPL. , pp. 30
    • Winer, E.S.1    Safran, H.2    Karaszewska, B.3
  • 13
    • 84863454665 scopus 로고    scopus 로고
    • Leukaemic transformation with romiplostim
    • Gardner K, Mathe S, Sahu S (2012) Leukaemic transformation with romiplostim. Br J Haematol 158:153
    • (2012) Br J Haematol , vol.158 , pp. 153
    • Gardner, K.1    Mathe, S.2    Sahu, S.3
  • 17
    • 28344456034 scopus 로고    scopus 로고
    • Venous thromboembolism: Disease burden, outcomes and risk factors
    • Heit JA (2005) Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost : JTH 3:1611-1617
    • (2005) J Thromb Haemost: JTH , vol.3 , pp. 1611-1617
    • Heit, J.A.1
  • 19
    • 27744485168 scopus 로고    scopus 로고
    • How I treat venous thromboembolism in patients with cancer
    • Prandoni P (2005) How I treat venous thromboembolism in patients with cancer. Blood 106:4027-4033
    • (2005) Blood , vol.106 , pp. 4027-4033
    • Prandoni, P.1
  • 20
    • 19944369810 scopus 로고    scopus 로고
    • Cancer and venous thromboembolism
    • DOI 10.1016/S1470-2045(05)70207-2, PII S1470204505702072
    • Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6:401-410 (Pubitemid 40753746)
    • (2005) Lancet Oncology , vol.6 , Issue.6 , pp. 401-410
    • Prandoni, P.1    Falanga, A.2    Piccioli, A.3
  • 21
    • 70449704426 scopus 로고    scopus 로고
    • Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
    • Kuter DJ, Mufti GJ, Bain BJ et al (2009) Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood 114:3748-3756
    • (2009) Blood , vol.114 , pp. 3748-3756
    • Kuter, D.J.1    Mufti, G.J.2    Bain, B.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.